BIOMARIN PHARMACEUTICAL INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Novato, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BIOMARIN PHARMACEUTICAL INC has filed 2,724 SEC EDGAR filings since 04 May 1999

SEC filing history

Showing 151-175 of 1,000 matching filings.

Per page
25
Current page
7
SC 13G/A File 005-56595

SCHEDULE 13G/A

Filing date
10 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56595

SC 13G/A filing

Filing date
08 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Jul 2024
Reporting date
28 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
04 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 May 2024
Reporting date
30 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
31 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 May 2024
Reporting date
28 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
30 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
30 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
30 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
29 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
28 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .